A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Santalum album (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Santalis Pharmaceuticals
- 15 Jan 2019 Planned End Date changed from 1 Apr 2018 to 1 Jan 2019.
- 15 Jan 2019 Planned primary completion date changed from 1 Mar 2018 to 1 Jan 2019.
- 15 Jan 2019 Planned initiation date changed from 1 Jan 2018 to 1 Jun 2018.